Neils B Quashie
Datos Biográficos
| ID | 10240600 |
|---|---|
| NOMBRE | Neils B Quashie |
| NOMBRES | Neils B |
| APELLIDO | Quashie |
| FIRMA | QUASHIE N B |
| AFILIACIONES | Noguchi Memorial Institute for Medical Research |
| ORCID | 0000-0002-2538-0324 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2026 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…
Sin obras prominentes en esta página.
Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Ghana, 2023
Introduction Malaria case management in Ghana is a key intervention within the national malaria elimination agenda. Currently, artesunate-amodiaquine (AS-AQ), artemetherlumefantrine (AL), and artesunate-pyronaridine (AP) are the first-line medicines for treating uncomplicated malaria whilst dihydroartemisinin-piperaquine (DHAP) is the second-line medicine. Methods This was a one-arm prospective evaluation of the clinical, parasitological and haem…
Clinical trial (1 obras) · Combination therapy (1 obras) · Diverse Scientific Research Studies (1 obras) · Malaria (1 obras) · Malaria Research and Control (1 obras) · Pharmaceutical Quality and Counterfeiting (1 obras) · Plasmodium falciparum (1 obras) · Protozoal disease (1 obras)